AIRBUS SE (AIR.PA)

Key Updates

Airbus shares declined 2.02% to $173.92 since the May 27th report, erasing the prior recovery gains and returning to near the A350 delay-induced lows from mid-May. The selloff was triggered by Bloomberg's revelation that China deliberately stalled aircraft approvals for several months to pressure European regulators on COMAC C919 certification, forcing Airbus to accumulate €5 billion in inventory during Q1. While management indicated the issue was resolved in late April, this geopolitical risk exposure significantly weakens the investment thesis, particularly given China represents Airbus's largest single-country market and the company faces concurrent A350 production challenges.

Current Trend

Airbus trades in a confirmed downtrend with YTD losses of 12.34% and 6-month declines of 9.69%. The stock has failed to establish sustainable support above €170, with the current price of $173.92 representing a 2.02% decline from the May 27th level of $177.50. The brief recovery from May 21-27 has been completely reversed, confirming resistance at the €177-178 zone. Near-term support sits at the May 21st low of €168.28, with the stock trading just 3.3% above that critical level. The consistent negative momentum across all timeframes (1-day: -3.22%, 1-month: -0.55%, 6-month: -9.69%) indicates sustained selling pressure without meaningful technical stabilization.

Investment Thesis

The investment thesis centers on Airbus's duopoly position in commercial aviation and its ability to capture Boeing's market share losses while scaling production to meet robust order backlogs. The company targets 870 commercial aircraft deliveries in 2026 and plans to double A350 production to 12 units monthly by 2028. The $19 billion AirAsia A220 order demonstrates continued commercial momentum in the narrowbody segment. However, this thesis faces material execution risks from supply chain disruption at the Spirit AeroSystems Kinston facility, geopolitical exposure to Chinese regulatory actions, and margin pressure from aggressive pricing on the A220 program. The combination of production delays and inventory accumulation threatens near-term cash flow generation, while China's willingness to weaponize aircraft certifications introduces structural uncertainty into delivery forecasts.

Thesis Status

The investment thesis has materially deteriorated since the May 27th report. The China certification stall revelation exposes critical geopolitical vulnerability that was not previously factored into the analysis, particularly given the €5 billion inventory accumulation impact on Q1 cash flows. While management claims resolution, the underlying issue—China's strategic use of certification delays as leverage for COMAC market access—remains unresolved and could recur. Combined with the A350 delays from the Spirit AeroSystems integration challenges, Airbus now faces simultaneous execution risks in both widebody production and its largest geographic market. The 870-aircraft delivery target for 2026 appears increasingly ambitious given these headwinds. The thesis requires reassessment of China exposure and supply chain normalization timelines before regaining credibility.

Key Drivers

The dominant near-term driver is geopolitical risk stemming from China's deliberate stalling of aircraft approvals, which resulted in approximately 20 aircraft unable to enter service and forced €5 billion in inventory accumulation during Q1 2026. This represents the lowest Q1 delivery count since 2009 and introduces structural uncertainty around Chinese market access. The second critical driver remains A350 production delays attributed to staffing issues at the Spirit AeroSystems Kinston facility, which compounds the postponement of the A350 freighter to H2 2027 and threatens the target of 12 monthly units by 2028. Positively, the $19 billion AirAsia A220 order validates narrowbody demand, though analysts note significant pricing discounts that pressure program economics. The interplay between Chinese regulatory actions and European certification of COMAC's C919 creates a zero-sum dynamic where Airbus market access may depend on facilitating direct competition in Western markets.

Technical Analysis

Airbus exhibits weak technical structure with the stock failing to hold the May 27th recovery high of $177.50, now trading 2.02% lower at $173.92. The brief rally from May 21-27 formed a lower high relative to pre-A350 delay levels, confirming resistance in the €177-178 zone. Critical support remains at €168.28 (May 21st low), just 3.3% below current levels, with a break potentially triggering accelerated selling toward €160. The stock trades well below all major moving averages, and the 12.34% YTD decline places it in the bottom quartile of European aerospace peers. Volume patterns suggest institutional distribution, with rallies met by consistent selling pressure. The failure to establish higher lows indicates absence of accumulation, while the -3.22% single-day decline on the China news demonstrates continued headline sensitivity. No bullish reversal patterns are evident, and momentum indicators remain in negative territory across all timeframes.

Bull Case

• Duopoly market structure with Boeing production constraints: Airbus maintains its position as one of two global commercial aircraft manufacturers, with Boeing facing ongoing quality and certification issues that drive airline customers toward Airbus. The company targets 870 aircraft deliveries in 2026, positioning it to capture market share during competitor weakness. Source
• $19 billion AirAsia order validates A220 commercial momentum: The 150-aircraft A220-300 order from AirAsia, with potential expansion to $38 billion for 300 total aircraft if the A220-500 is developed, demonstrates sustained demand for the narrowbody program and strengthens Airbus's Canadian manufacturing base. Source
• China certification issue reportedly resolved: Airbus CEO Guillaume Faury stated in late April that the Chinese aircraft approval delays had been resolved, with undelivered planes scheduled to ship in Q2 2026, potentially normalizing the delivery cadence and reducing the €5 billion inventory accumulation. Source
• A220 production scaling toward profitability: Airbus is ramping A220 production to 12 units monthly by 2026 and 13 monthly by 2028, with the increased production rates expected to drive the program toward profitability following its 2018 acquisition from Bombardier. Source
• A350 production doubling target by 2028: Despite current delays, Airbus maintains its goal of doubling A350 production to 12 units monthly by 2028, which would significantly increase widebody revenue and improve program economics as the aircraft captures market share from Boeing's 787 and 777 programs. Source

Bear Case

• Geopolitical weaponization of Chinese market access: China deliberately stalled Airbus aircraft approvals for several months to pressure European regulators on COMAC C919 certification, resulting in approximately 20 aircraft unable to enter service and €5 billion in Q1 inventory accumulation—the lowest Q1 deliveries since 2009. This establishes precedent for recurring regulatory interference in Airbus's largest single-country market. Source
• A350 delivery delays from Spirit AeroSystems integration failures: Staffing issues at the recently acquired Spirit AeroSystems facility in Kinston, North Carolina, are causing A350 delivery delays later this decade, compounding the postponement of the A350 freighter launch to H2 2027 and creating additional challenges for the 12-unit monthly production target by 2028. Source
• COMAC C919 European certification threatens core narrowbody market: European aviation regulators are conducting test flights to assess COMAC's C919 for EASA certification, which would enable the Chinese aircraft to compete directly with the A320 family in Western markets, potentially eroding Airbus's narrowbody dominance in exchange for Chinese market access. Source
• Aggressive A220 pricing pressure on program economics: Industry analysts note that AirAsia negotiated significant price discounts on the $19 billion A220 order, placing pressure on Airbus to accelerate production beyond current rates to achieve profitability on the program, while the requirement to develop the A220-500 variant adds development costs. Source
• Sustained negative momentum across all timeframes: The stock exhibits consistent selling pressure with declines across 1-day (-3.22%), 1-month (-0.55%), 6-month (-9.69%), and YTD (-12.34%) periods, failing to establish support above €170 and trading just 3.3% above the May 21st low of €168.28, indicating absence of institutional accumulation. Source